Also known as: 9-cis-retinoic acid Alitretinoin
Alitretinoin is indicated for:
Population group: men, only adults (18 - 65 years old)
Alitretinoin is indicated for the topical treatment of cutaneous lesions in patients with AIDS related Kaposi’s sarcoma (KS) when:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only adults (18 - 65 years old)
Alitretinoin is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids.
Patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Alitretinoin is contraindicated in the following cases: